Moreover, in addition to promoting tumor cell extravasation via local release of VEGF-A [108], CCR2-expressing monocytes give rise to immune-suppressive MAM-precursors that exhibit resistance to CSF-1 blockade [69] and promote pulmonary seeding of mammary carcinoma cells [107]. The gene discussed is CCR2; the disease is breast carcinoma.